Fidelity Investments’s BioTime Inc Warrants (Expiring October 1, 2018) BTX.WS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-30,115
| Closed | -$2K | – | 3916 |
|
|
2018
Q2 | $2K | Hold |
30,115
| – | – | ﹤0.01% | 2625 |
|
|
2018
Q1 | $3K | Hold |
30,115
| – | – | ﹤0.01% | 2657 |
|
|
2017
Q4 | $4K | Hold |
30,115
| – | – | ﹤0.01% | 2646 |
|
|
2017
Q3 | $6K | Hold |
30,115
| – | – | ﹤0.01% | 2590 |
|
|
2017
Q2 | $10K | Hold |
30,115
| – | – | ﹤0.01% | 2611 |
|
|
2017
Q1 | $18K | Hold |
30,115
| – | – | ﹤0.01% | 2640 |
|
|
2016
Q4 | $21K | Sell |
30,115
-98,063
| -77% | -$66.7K | ﹤0.01% | 2644 |
|
|
2016
Q3 | $104K | Hold |
128,178
| – | – | ﹤0.01% | 2637 |
|
|
2016
Q2 | $60K | Hold |
128,178
| – | – | ﹤0.01% | 2639 |
|
|
2016
Q1 | $81K | Hold |
128,178
| – | – | ﹤0.01% | 2645 |
|
|
2015
Q4 | $136K | Hold |
128,178
| – | – | ﹤0.01% | 2706 |
|
|
2015
Q3 | $108K | Hold |
128,178
| – | – | ﹤0.01% | 2698 |
|
|
2015
Q2 | $142K | Hold |
128,178
| – | – | ﹤0.01% | 2703 |
|
|
2015
Q1 | $256K | Buy |
128,178
+2
| +0% | +$3 | ﹤0.01% | 2702 |
|
|
2014
Q4 | $135K | Buy |
+128,176
| New | +$139K | ﹤0.01% | 2763 |
|
Fidelity Investments's BTX.WS Position: Q3 2018 in Review
Fidelity Investments sold out of BioTime Inc Warrants (Expiring October 1, 2018) (BTX.WS) in Q3 2018, closing a stake of 30,115 shares — an estimated $2K sold.
Fidelity Investments first reported a position in BTX.WS in Q4 2014 and held it in 15 quarters. The position peaked at $256K in Q1 2015. 7 funds tracked by Wall St. Rank hold BTX.WS as of Q3 2018.
- Fidelity Investments reported no remaining BioTime Inc Warrants (Expiring October 1, 2018) position as of Q3 2018 after selling out during the quarter.
- Fidelity Investments sold 30,115 BioTime Inc Warrants (Expiring October 1, 2018) shares in Q3 2018, an estimated $2K.
- Fidelity Investments first reported a position in BioTime Inc Warrants (Expiring October 1, 2018) in Q4 2014 and held it in 15 quarters.
- Fidelity Investments's BioTime Inc Warrants (Expiring October 1, 2018) position peaked at $256K in Q1 2015.
- 7 funds tracked by Wall St. Rank held BioTime Inc Warrants (Expiring October 1, 2018) as of Q3 2018.
Based on Fidelity Investments's 13F filing for Q3 2018, filed 9 Nov 2018.